Showing results (61-70 of 761) with videos related to
Sort By:
Pageof 77
Nephron|November 5, 2023
Functional Magnetic Resonance Imaging to Monitor Disease Progression: A Prospective Study in Patients with Primary Membranoproliferative GlomerulonephritisGiulia Villa, Erica Daina, Paolo Brambilla, et al.Journal of the American Society of Nephrology : JASN|June 7, 2014
A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulationElisabetta Valoti, Marta Alberti, Agustin Tortajada, et al.Kidney International|August 14, 2010
Toward a B-cell signature of tolerance?Daniela Cugini, Marina NorisImmunological Reviews|October 22, 2022
The complement alternative pathway and hemostasisMarina Noris, Miriam GalbuseraHypertension (Dallas, Tex. : 1979)|January 28, 2004
L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant speciesMarina Noris, Marta Todeschini, Paola Cassis, et al.Molecular Immunology|July 23, 2023
Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulationCristina Zanchi, Monica Locatelli, Daniela Corna, et al.Kidney International|December 1, 2010
Klotho in acute kidney injury: biomarker, therapy, or a bit of both?Sistiana Aiello, Marina NorisTransplantation|June 28, 2011
Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in ratsPaola Cassis, Nadia Azzollini, Samantha Solini, et al.Frontiers in Immunology|February 16, 2023
<i>CFH</i> and <i>CFHR</i> structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcomeRossella Piras, Elisabetta Valoti, Marta Alberti, et al.Molecular Immunology|February 18, 2024
Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathyCristina Zanchi, Monica Locatelli, Domenico Cerullo, et al.Pageof 77